Jefferies Group LLC Puma Biotechnology, Inc. Call Options Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$12.3 - $35.76 $1.11 Million - $3.22 Million	-90,100 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$20.77 - $42.37 $884,802 - $1.8 Million	42,600 Added 89.68%	90,100 $3.5 Million
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $103,000 - $149,625	2,500 Added 5.56%	47,500 $2.18 Million
Q2 2018 Aug 14, 2018	BUY	$48.3 - $68.25 $2.17 Million - $3.07 Million	45,000 New	45,000 $2.66 Million

110

28.3M

27.9K

3.4K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $156M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.